Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 1/2023

02-01-2023 | Correction

Correction: Selenium-sensitive histone deacetylase 2 is required for forkhead box O3A and regulates extracellular matrix metabolism in cartilage

Authors: Yitong Zhao, Yuanxu Guo, Mengyao Sun, Safdar Hussion, Ying Zheng, Huang Huang, Xinyu Huo, Yutong Zhao, Fujun Zhang, Yan Han, Qilan Ning, Peng Xu, Jian Sun, Shemin Lu

Published in: Journal of Bone and Mineral Metabolism | Issue 1/2023

Login to get access

Excerpt

Correction: Journal of Bone and Mineral Metabolism (2022) 40:914–926 https://doi.org/10.1007/s00774-022-01369-9
Metadata
Title
Correction: Selenium-sensitive histone deacetylase 2 is required for forkhead box O3A and regulates extracellular matrix metabolism in cartilage
Authors
Yitong Zhao
Yuanxu Guo
Mengyao Sun
Safdar Hussion
Ying Zheng
Huang Huang
Xinyu Huo
Yutong Zhao
Fujun Zhang
Yan Han
Qilan Ning
Peng Xu
Jian Sun
Shemin Lu
Publication date
02-01-2023
Publisher
Springer Nature Singapore
Published in
Journal of Bone and Mineral Metabolism / Issue 1/2023
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-022-01395-7

Other articles of this Issue 1/2023

Journal of Bone and Mineral Metabolism 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine